Exelixis
(NASDAQ) EXEL
Exelixis Financials at a Glance
Market Cap
$11.11B
Revenue (TTM)
$2.32B
Net Income (TTM)
$782.57M
EPS (TTM)
$2.78
P/E Ratio
15.37
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$42.72
Volume
0
Open
$42.17
Price
$42.72
Volume
0
Open
$42.17
Previous Close
$42.72
Daily Range
$42.06 - $43.46
52-Week Range
$32.38 - $49.62
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$42.72
Volume
0
Open
$42.17
Previous Close
$42.72
Daily Range
$42.06 - $43.46
52-Week Range
$32.38 - $49.62
EXEL News
EXEL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Exelixis
Industry
Biotechnology
Sector
Health CareEmployees
1,077
CEO
Michael M. Morrissey, PhD
Website
www.exelixis.comHeadquarters
Alameda, CA 94502, US
EXEL Financials
Key Financial Metrics (TTM)
Gross Margin
96%
Operating Margin
38%
Net Income Margin
34%
Return on Equity
36%
Return on Capital
36%
Return on Assets
28%
Earnings Yield
6.51%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.11B
Shares Outstanding
259.71M
Volume
0
Short Interest
0.00%
Avg. Volume
2.80M
Financials (TTM)
Gross Profit
$2.24B
Operating Income
$872.19M
EBITDA
$921.76M
Operating Cash Flow
$884.27M
Capital Expenditure
$39.93M
Free Cash Flow
$844.34M
Cash & ST Invst.
$1.06B
Total Debt
$173.04M
Exelixis Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$598.66M
+5.6%
Gross Profit
$572.18M
+4.6%
Gross Margin
95.58%
N/A
Market Cap
$11.11B
N/A
Market Cap/Employee
$9.69M
N/A
Employees
1,147
N/A
Net Income
$244.53M
+74.8%
EBITDA
$242.86M
+41.9%
Quarterly Fundamentals
Net Cash
$886.05M
-3.7%
Accounts Receivable
$286.92M
+8.1%
Inventory
$21.69M
-3.1%
Long Term Debt
$173.04M
-9.3%
Short Term Debt
$0.00
N/A
Return on Assets
27.51%
N/A
Return on Invested Capital
35.76%
N/A
Free Cash Flow
$332.36M
+46.9%
Operating Cash Flow
$333.51M
+38.8%